What Are the Long-Term Cardiovascular Outcomes of Growth Hormone Secretagogue Use?
Growth hormone secretagogues present divergent cardiovascular outcomes, with GHRH analogues reducing risk and ghrelin mimetics increasing it.
HRTioAugust 23, 2025





























